PharmaShots | Incisive News in 3 Shots

Subscribe Now

Prefilled Syringe

Novartis's Xolair (omalizumab) Prefilled Syringe for Self-Injection Receives the US FDA's Approval Across All Indications

Novartis's Xolair (omalizumab) Prefilled Syringe for Self-Injection Receives the US FDA's Approval Across All Indications

April 13, 2021

PharmaShots Interview: Genentech's Ted Omachi Shares Insights on Xolair (omalizumab) PFS

PharmaShots Interview: Genentech's Ted Omachi Shares Insights on Xolair (omalizumab) PFS

September 7, 2020

Roche Reports the US FDA's Acceptance of sBLA for Xolair (omalizumab) Prefilled Syringe for Self-Administration Across All Indications

Roche Reports the US FDA's Acceptance of sBLA for Xolair (omalizumab) Prefilled Syringe for Self-Administration Across All Indicat...

August 13, 2020

AstraZeneca's Forxiga and Fasenra (Prefilled Syringe and Pen) Receive EU CHMP's Positive Opinion for CV Outcomes in T2D and Asthma

AstraZeneca's Forxiga and Fasenra (Prefilled Syringe and Pen) Receive EU CHMP's Positive Opinion for CV Outcomes in T2D and Asthma

July 1, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us